deCODE genetics, Inc. (DCGN) Files Voluntary Chapter 11 Petition to Facilitate Sale of Assets
11/17/2009
More...
|
Fate Therapeutics (JOBS) Closes $30 Million Series B Financing
11/16/2009
More...
|
Altus Pharmaceuticals Inc. (ALTU) Files for Chapter 7 Bankruptcy
11/12/2009
More...
|
Dynavax Technologies Corporation (DVAX) to Acquire Symphony Dynamo, Inc., Including $20 Million in Unrestricted Cash
11/10/2009
More...
|
Trius Therapeutics Files for IPO
11/9/2009
More...
|
Alimera Sciences Re-Files for IPO
11/2/2009
More...
|
Omeros Corporation, First U.S. Biotech IPO Since February 2008, Sees Shares Drop 13 Percent in First Day
10/9/2009
More...
|
Repros Therapeutics Inc. (RPRX) Announces Financing
10/8/2009
More...
|
Epizyme Closes $32 Million Series B Financing, Led by New Investor Bay City Capital
10/8/2009
More...
|
Auxilium Pharmaceuticals (AUXL) Completes Sale of 3.45 Million Shares of Common Stock Resulting in $115.7 Million in Net Proceeds
10/1/2009
More...
|
Vertex Pharmaceuticals (CA) (VRTX) (JOBS) to Receive $155 Million in Cash Related to Future Telaprevir Milestone Payments
10/1/2009
More...
|
Valeant Pharmaceuticals International (VRX) Buys-Out Rights to All Current and Future Income and Milestone Obligations From Former Dow Pharmaceutical Sciences (JOBS) Stockholders for $115M
9/29/2009
More...
|
Calypso Medical Technologies Raises $50 Million
9/21/2009
More...
|
Omeros Corporation Announces IPO of 6.8 Million Shares
9/18/2009
More...
|
Juvaris BioTherapeutics Announces First Close on $25 Million Series B Financing
9/17/2009
More...
|
Anthera Pharmaceuticals, Inc. Plans $70 Million IPO
9/16/2009
More...
|
Talecris Biotherapeutics (TLCR) (JOBS) Plans IPO
9/15/2009
More...
|
arGEN-X Raises EUR 9.5 Million; Deal co-led By Forbion Capital Partners And LSP
9/10/2009
More...
|
Seattle Genetics, Inc. (SGEN) (JOBS) Gets Stock Offering Totalling $136 Million
8/14/2009
More...
|
Emdeon Corporation (HLTH) IPO Rises 6.6%, Ending Off Day's High
8/13/2009
More...
|
Cumberland Pharmaceuticals (CPIX) Raises $85 Million IPO, First Pharma IPO in Nearly Two Years
8/12/2009
More...
|
Inspire Pharmaceuticals, Inc. (ISPH) Announces Closing of $115 Million Public Offering
8/11/2009
More...
|
Onyx Pharmaceuticals, Inc. (ONXX) Announces Concurrent Offerings of Four Million Shares of Common Stock and $200 Million Principal Amount of Convertible Senior Notes
8/5/2009
More...
|
Micromet Closes $80.5 Million Public Offering of Common Stock
8/4/2009
More...
|
Human Genome Sciences, Inc. (HGSI) To Raise $310M In Stock Offering
7/29/2009
More...
|
Oscient Pharmaceuticals Corporation (OSCI) Files for Bankruptcy; Sell its Antibiotic Drug Factive to Cornerstone Therapeutics Inc. Unit for $5 Million
7/14/2009
More...
|
Vertex Pharmaceuticals Incorporated (VRTX) to Sell Rights to Hepatitis C Drug Payments
7/10/2009
More...
|
Arena Pharmaceuticals, Inc. (ARNA) Announces Pricing of Public Offering of Common Stock
7/8/2009
More...
|
XenoPort, Inc. (XNPT) Announces Proposed Public Offering of Common Stock
7/8/2009
More...
|
Intellikine, Inc. Completes $51 Million Financing
7/8/2009
More...
|
Jazz Pharmaceuticals, Inc. (JAZZ) Completes $7 Million Private Placement
7/7/2009
More...
|
Medidata Solutions, Inc. Prices Initial Public Offering
6/25/2009
More...
|
Jazz Pharmaceuticals, Inc. (JAZZ) Puts 3 Drug Candidates on Hold to Help Service Debt
6/23/2009
More...
|
Halozyme Therapeutics, Inc. (HALO) Raises $40 Million in Public Offering of Common Stock
6/23/2009
More...
|
Arena Pharmaceuticals, Inc. (ARNA) to Receive $100 Million from Deerfield Management
6/18/2009
More...
|
Alios BioPharma Closes $32 Million Series A Financing
6/11/2009
More...
|
GlaxoSmithKline (GSK), Novartis Corporation (NVS) (JOBS), Roche (RHHBY) (JOBS), Eli Lilly and Company (LLY) (JOBS) Back Biotech Aileron Therapeutics in $40 Million Fundraising
6/9/2009
More...
|
Johnson & Johnson (JNJ) (JOBS) to Acquire Cougar Biotechnology, Inc. (CGRB.OB) for About $970 Million
5/22/2009
More...
|
Lonza Group Ltd. to Invest $150 Million in Genome Valley
5/22/2009
More...
|
Clovis Oncology Raises $145 Million in Start-Up Financing
5/21/2009
More...
|
Sanofi-Aventis (France) (SASY.PA) Signs $315 Million Deal with Kyowa Hakko
5/14/2009
More...
|
Dendreon Corporation (DNDN) to Offer Shares to Back Vaccine Sale
5/8/2009
More...
|
VaxInnate Corporation Closes $30 Million Round of Financing; Wellcome Trust Leads Round
5/6/2009
More...
|
Calistoga Pharmaceuticals Raises $30 Million in Series B Financing
5/5/2009
More...
|
RegeneRx Biopharmaceuticals, Inc. (RGRX) Announces Financing Transaction and 35% Reduction in Salaries
4/13/2009
More...
|
Marinus Pharmaceuticals Raises $20 Million in Series B Financing
4/10/2009
More...
|
Alimera Sciences Cancels IPO
4/9/2009
More...
|
EPIX Pharmaceuticals, Inc. (EPIX) to Go Bankrupt if Debt Restructuring Fails
4/7/2009
More...
|
Sunesis Pharmaceuticals, Inc. (SNSS) Announces Up To $43.5 Million Financing
4/1/2009
More...
|
Arena Pharmaceuticals, Inc. (ARNA) Obtains Equity Financing Commitment of Up to $50 Million
3/24/2009
More...
|
GTCR Golder Rauner, LLC Forms Pharma Acquisition Platform, Actient Pharmaceuticals LLC; GTCR to Invest $200 Million in Actient
3/24/2009
More...
|
Merck Serono Launches Biotech Venture Capital Fund
3/23/2009
More...
|
SFJ Pharma Raises $45 Million
3/16/2009
More...
|
Pfizer Inc. (PFE) (JOBS) Plans 4-Part Bond to Finance Wyeth (WYE) (JOBS) Buy-Lead
3/16/2009
More...
|
Sangart, Inc. Completes $50 Million Series F Funding Round
3/12/2009
More...
|
Roche Holding AG (RHHBF.PK) Sells $16 Billion in 6-Part Debt Sale
2/19/2009
More...
|
Vertex Pharmaceuticals Incorporated (VRTX) Says It Plans to Sell 10 Million New Shares
2/19/2009
More...
|
Sopherion Therapeutics, Inc. Secures $55 Million in Series C Funding
2/19/2009
More...
|
Algeta Raises $35 Million in a Private Placement
2/18/2009
More...
|
Mead Johnson Nutrition Company $720 Million IPO Breaks 12-week Drought
2/11/2009
More...
|
Akesis Pharmaceuticals Discontinues Sole Clinical Development Program and Announces Intent to File for Chapter 7 Bankruptcy
1/22/2009
More...
|
Biotechnology Value Fund, L.P. To Make Tender Offer For Any And All Outstanding Shares Of Avigen, Inc. (AVGN) At $1.00 Per Share or Roughly $20.5 Million
1/16/2009
More...
|
Amgen (AMGN) (JOBS) Sells $2 Billion of Debt in Two-part Sale
1/14/2009
More...
|
Satori Pharmaceuticals Raises $22M; Names Former Senior Pfizer Executive as CEO
1/8/2009
More...
|
Intuitive Surgical, Inc. (ISRG) Q4 Revenue Miss Wall Street Expectations
1/8/2009
More...
|
Momenta Pharmaceuticals, Inc. (MNTA) to Raise $24.1 Million Through Registered Direct Offering
12/12/2008
More...
|
NitroMed, Inc. (NTMD) Receives Unsolicited Acquisition Proposal from Deerfield Management
12/5/2008
More...
|
Introgen Therapeutics, Inc. (INGN) Files for Bankruptcy, Sees Exit in 2009
12/4/2008
More...
|
Catalyst Biosciences, Inc. Raises $40 Million in Series C Financing
12/3/2008
More...
|
Prospects of $45 Billion Loan for Roche (RHHBY) (JOBS) Receding
12/1/2008
More...
|
King Pharmaceuticals®, Inc. Mulls Alternative Financing for {2} Deal
11/26/2008
More...
|
Ascent Therapeutics Debuts with the Appointment of CEO; $19 Million Series A
11/18/2008
More...
|
Pacira Pharmaceuticals, Inc. Raises $85 Million
11/17/2008
More...
|
ChemoCentryx, Inc. Cancels IPO
11/17/2008
More...
|
StemCells Inc. (STEM) to Raise $20M in Stock Sale
11/12/2008
More...
|
Morganthaler Closes Ninth Fund at $400 Million
11/12/2008
More...
|
OncoMed Pharmaceuticals, Inc. Completes $154 Million Series B Financing
11/4/2008
More...
|
CeNeRx BioPharma, Inc. Completes $15 Million Series B Financing
10/17/2008
More...
|
deCODE genetics, Inc. (DCGN) Conducting Strategic Review to Sharpen the Focus of its Long-term Business
10/16/2008
More...
|
Carlsbad Biotech Company, Orchestra Therapeutics (OCHTZ) Files Bankruptcy
10/16/2008
More...
|
Proteus Biomedical, Inc. Raises $32 Million in Series D Funding
10/15/2008
More...
|
AtheroGenics (AGIX) Files for Chapter 11 Bankruptcy
10/7/2008
More...
|
Daiichi Sankyo Co Ltd. Says Offer for Ranbaxy Laboratories Oversubscribed
9/24/2008
More...
|
Fluidigm Corporation Pushing Forward with IPO
9/22/2008
More...
|
Lumira Capital (Formerly MDS Capital) Raising New Fund; Seeks Up To $300M
9/19/2008
More...
|
Vertex Pharmaceuticals Incorporated (VRTX) Announces Proposed Public Offering of Common Stock
9/18/2008
More...
|
Mylan Inc. Completes $575 Million Cash Convertible Note Offering, Including Exercise of Overallotment Option
9/16/2008
More...
|
Accelerator Corporation Bankrolls New Company, Mirina Corporation, To Develop MicroRNA-Blocking Drugs
8/15/2008
More...
|
TPG Ventures Seeks $550 Million for Third Biotech Fund
8/14/2008
More...
|
InterWest Partners Closes $650 Million Fund
8/12/2008
More...
|
Icahn Buys More Biogen Idec, Inc. (Massachusetts) (BIIB) on Tysabri Dip
8/12/2008
More...
|
Zogenix, Inc. Cancels IPO
8/5/2008
More...
|
AutoGenomics Files Registration Statement for Initial Public Offering
7/25/2008
More...
|
BG Medicine Closes $40 Million in Series D Financing
7/17/2008
More...
|
Agios Pharmaceuticals Closes $33 Million Series A Funding
7/7/2008
More...
|
Venture Capital Investment Holds Steady At $7.4 Billion In Q2 2008 According To The Moneytree Report
7/1/2008
More...
|
Abbott Laboratories (ABT) (JOBS) Invests Additional $20M in Isis' Subsidiary {2}
7/1/2008
More...
|
IPO Drought Creates Capital Market Crisis for Start-Up Community
7/1/2008
More...
|
Jazz Pharmaceuticals, Inc. (JAZZ) Files for $100 Million Shelf
6/12/2008
More...
|
Novartis AG Recommends Rejection of ''Mini-tender'' Offer by TRC Capital for American Depositary Shares
6/12/2008
More...
|
Peplin Inc. Files to Withdraw IPO Plans
6/10/2008
More...
|
Exelixis, Inc. (EXEL) Receives $150 Million Funding Commitment From Deerfield Management
6/5/2008
More...
|
Genta Incorporated (GNTA) Secures Up to $40 Million Convertible Financing Facility to Fund Key Programs
6/5/2008
More...
|
Ernst & Young LLP: Record Venture Capital And Heated Deal Environment Propel Global Biotechnology Industry Forward In 2007
5/23/2008
More...
|
Aldagen, Inc. Files for $80.5 Million IPO
5/12/2008
More...
|
Elixir Pharmaceuticals Withdraws IPO Plans
5/12/2008
More...
|
Array BioPharma, Inc. (ARRY) Receives $80 Million Funding Commitment
5/6/2008
More...
|
GlaxoSmithKline (GSK) Plans to Sell $6 Billion 3-tranche Bond
5/6/2008
More...
|
Esperion Therapeutics, Inc. Completes $22.75 M Series A Financing
5/1/2008
More...
|
BrainCells Inc. Expands Series B Financing to $50 Million
4/18/2008
More...
|
CV Therapeutics, Inc. (CVTX) Announces $185 Million Transaction with TPG-Axon Capital for Half of Royalty for Lexiscan(TM) (regadenoson) Injection; Stocks Rise
4/16/2008
More...
|
Codexis, Inc. Files for $100M IPO
4/14/2008
More...
|
VIVUS, Inc. (VVUS) Enters into $30 Million Funding Collaboration for the Phase 3 Studies of Avanafil for Erectile Dysfunction
4/4/2008
More...
|
Plethora Solutions Holdings and Paul Capital Healthcare Sign a $25M Revenue Interest Financing Agreement
4/1/2008
More...
|
Recodagen Corporation is Seventh New Start-Up Launched by Accelerator Corporation
3/14/2008
More...
|
Shire Pharmaceuticals (SHPGY) Climbs on Talk of Pfizer Inc. (PFE) Bid Interest
3/14/2008
More...
|
Bostwick Laboratories Files for $100M IPO
3/10/2008
More...
|
BrainCells Inc. Completes $30 Million Initial Closing of Series B Financing
3/10/2008
More...
|
EKR Therapeutics, Inc. Raises Over $145 Million in Support of Growth
3/10/2008
More...
|
Pfizer Inc. (PFE) to Acquire Encysive Pharmaceuticals (ENCY) and Thelin Lung Drug for About $195M
2/20/2008
More...
|
Vertex Pharmaceuticals Incorporated (VRTX) Announces Pricing of its Concurrent Public Offerings of Common Stock and Convertible Senior Subordinated Notes
2/13/2008
More...
|
Light Sciences Oncology, Inc. Withdraws IPO Plans; Cites Market Conditions
2/11/2008
More...
|
Biolex, Inc. Pulls Planned IPO Due to Market Conditions
2/4/2008
More...
|
Bristol-Myers Squibb Company (BMY) Hit by Credit Crisis
1/31/2008
More...
|
Alder Biopharmaceuticals Inc. Completes $40M Series C Financing
1/11/2008
More...
|
Omeros Corporation Files for $115 Million IPO
1/10/2008
More...
|
Bayhill Therapeutics, Inc. Files for $86.25M IPO
1/9/2008
More...
|
Antigenics Inc. (New York) (AGEN) to Raise $26 Million in Private Placement
1/9/2008
More...
|
MedImmune, Inc. Broadens Focus of Venture Capital Fund to Include New Therapeutic Areas; Expands Staff to Continue Record of Investment Success
1/7/2008
More...
|
REVA Medical Inc. Raises $42 Million in Private Financing
12/11/2007
More...
|
Private Equity Firm Plans $1.5 Billion Drug-Deal Fund
12/11/2007
More...
|
Pelikan Technologies, Inc. (Jobs) Closes $69 Million Series F Financing and Secures a Further $20 Million in Debt Financing; One of the Largest Medical Device Company Financings of 2007 will Fund Launch of Next Generation Glucose Monitoring Products
12/6/2007
More...
|
Medgenics, Inc. Raises £3.28 Million IPO
11/30/2007
More...
|
Mylan Laboratories Inc. (MYL) Nets About $2.8 Billion in Share Offering
11/20/2007
More...
|
Ambit Biosciences Raises Over $49 Million in Series D Financing
11/14/2007
More...
|
Xanodyne Pharmaceuticals, Inc. Files to Go Public
11/12/2007
More...
|
ARYx Therapeutics, Inc. IPO Raises $50 Million
11/7/2007
More...
|
Arena Pharmaceuticals, Inc. (ARNA) Raises $109 Million
11/2/2007
More...
|
Merrion Pharmaceuticals, Inc. Cuts IPO Price Range to $6-$7 per ADS
10/30/2007
More...
|
Genoptix, Inc. IPO Raises $85 Million
10/30/2007
More...
|
Transoma Medical Files Registration Statement for $75 Million IPO
10/12/2007
More...
|
Targanta Therapeutics IPO Fails to Fire up Investors
10/11/2007
More...
|
Metastatix, Inc. Closes $35 Million Series B Financing
10/9/2007
More...
|
Genoptix, Inc. (Jobs) Sees IPO of 5 Million Shares at $14-$16 Each
10/9/2007
More...
|
MAP Pharmaceuticals, Inc. (MAPP) Announces Pricing of Its Initial Public Offering
10/5/2007
More...
|